The implantable defibrillator with subcutaneous leads, designed in part to minimize the risk for potentially serious lead-related complications, has reached a milestone by turning in a "noninferior" ...

SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...

Please provide your email address to receive an email when new articles are posted on . Transvenous ICD leads are associated with tricuspid regurgitation compared with subcutaneous ICDs. More research ...

SAN FRANCISCO — An implantable cardioverter defibrillator (ICD) with a lead system that inserts just below the sternum performed promisingly in a recent early experience that sets the stage for a more ...

NATICK, Mass., /PRNewswire/ -- Boston Scientific Corporation has conducted the first implant in the clinical trial of the next generation ACUITY™ X4 left-ventricular (LV) pacing leads and RELIANCE™ ...

Please provide your email address to receive an email when new articles are posted on . Researchers have developed a risk model to help predict the chances of adverse events after a patient receives ...

SAN CLEMENTE, Calif., April 24, 2024 /PRNewswire/ -- AtaCor Medical Inc., a privately-held medical device company delivering the next generation of extravascular leads to advance the care of cardiac ...

A new Canadian study reports an alternative way to connect leads to cardiac defibrillators. Leads are special connectors or wires that deliver energy from an implantable cardioverter defibrillator ...